publication . Article . 2021

Cognitive impairment in COVID-19 survivors

N. V. Pizova; N. A. Pizov; A. V. Pizov;
Open Access Russian
  • Published: 01 Feb 2021 Journal: Медицинский совет, issue 4, pages 69-77 (issn: 2658-5790, Copyright policy)
  • Publisher: Remedium Group LLC
A new 2019 coronavirus disease has been spreading worldwide for more than a year, with a high risk of infection and death. Various sequelae and complications can develop in COVID-19 survivors, lasting from several weeks to several months after initial recovery, affecting different organs and systems. Various sequelae and complications can occur in COVID-19 survivors not only in adults and the elderly, but also in young people. A wide range of neurological manifestations of COVID-19 are now described in the available literature. The incidence of selected neurological symptoms, syndromes and nosological forms in individuals both in the acute period of COVID-19 dis...
free text keywords: coronavirus disease, cognitive impairment, drug and non-drug rehabilitation, citicoline, neuroprotection, Medicine, R, Psychiatry and Mental health, Clinical Neurology, Clinical Psychology, covid-19, Neurology. Diseases of the nervous system, RC346-429
Any information missing or wrong?Report an Issue